Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune homeostasis, today announced a corporate restructuring to ...

Application segment, which is expected to reach US$1.3 Billion by 2030 with a CAGR of a 8%. The AISS (Clinical) Application ...

The roof coating market has witnessed a boom with the introduction of silicone coatings, which are extremely durable, water-resistant, and favorable against extreme weather conditions. These have ...

Researchers create polyesteramides from brassylic acid and explore their potential as a replacement for polyethylene ...